Allogene Therapeutics, Inc. (NASDAQ:ALLO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Vicki Sato Other companies: Vir Biotechnology, Inc. (Director · Since at least Oct 10, 2019); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Denali Therapeutics Inc. (Director · Dec 7, 2017 – Jan 2, 2025 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 29, 2016 – Jun 11, 2019 · Past); BorgWarner Inc. (Director · Feb 12, 2014 – Apr 29, 2020 · Past); Alnylam Pharmaceuticals, Inc. (Director · Jun 1, 2007 – Jun 2, 2010 · Past); Bristol-Myers Squibb Company (Director · Jul 11, 2006 – Feb 1, 2021 · Past); Revvity, Inc. (Director · May 2, 2006 – Feb 9, 2017 · Past) | Director · Since at least Jul 30, 2021 |
| Timothy L Moore Other companies: BioLife Solutions, Inc. (Director · Since at least Sep 1, 2022); Cerus Corporation (Director · Since at least Sep 5, 2018); Instil Bio, Inc. (Chief Operating Officer · Sep 6, 2022 – Sep 6, 2022 · Past); Kite Pharma Inc (EVP, Technical Operations · Mar 15, 2016 – Oct 3, 2017 · Past) | Chief Technical Officer · Apr 24, 2023 – Feb 3, 2025 · Past |
| Arie Belldegrun Other companies: UroGen Pharma Ltd. (Director · Since at least Mar 24, 2021); Kronos Bio Inc (Director · Since at least Oct 8, 2020); Ginkgo Bioworks Holdings, Inc. (Director · Sep 16, 2021 – Jun 12, 2024 · Past) | Director · Since at least Mar 26, 2021 |
| Elizabeth A Barrett Other companies: Sage Therapeutics Inc (Director · Since at least Jun 11, 2025); UroGen Pharma Ltd. (Chief Executive Officer · Since at least Jan 3, 2019); LifeSci Acquisition II Corp (Director · Nov 20, 2020 – Nov 20, 2020 · Past) | Director · Since at least Jul 30, 2021 |
| Rafael G. Amado Other companies: Zai Lab Ltd. (President, Head of Global Research and Development · Since at least Dec 30, 2022); Poseida Therapeutics Inc (Director · Apr 13, 2023 – Jan 8, 2025 · Past); Adaptimmune Therapeutics PLC (President, R&D · Jan 1, 2016 – Aug 6, 2019 · Past) | EVP of R&D · Sep 3, 2019 – Oct 7, 2022 · Past |
| Deborah M Messemer Other companies: TPG Inc. (Director · Since at least Jan 13, 2022); PayPal Holdings, Inc. (Director · Since at least May 26, 2021) | Director · Since at least Jun 10, 2021 |
| Eric Thomas Schmidt Other companies: Revolution Medicines, Inc. (Director · Jun 17, 2020 – Jun 8, 2023 · Past); Relmada Therapeutics, Inc. (Director · Dec 19, 2019 – May 25, 2023 · Past) | Chief Financial Officer · Oct 10, 2018 – Mar 22, 2023 · Past |
| Geoffrey Parker Other companies: Perrigo Company plc (Director · Since at least May 14, 2024); Better Therapeutics, Inc. (Director · Dec 18, 2023 – Dec 18, 2023 · Past) | CHIEF FINANCIAL OFFICER · Since at least Oct 16, 2023 |
| Stephen L. Mayo Other companies: Sarepta Therapeutics, Inc. (Director · Since at least Nov 16, 2021); Merck & Company, Inc. (Board Member · Since at least Mar 15, 2021) | Bren Professor of Biology and Chemistry and Merkin Institute Professor · Since at least Jul 8, 2022 |
| David Chang Other companies: Kite Pharma Inc (EVP, R&D, Chief Medical Off. · Jun 19, 2014 – Oct 3, 2017 · Past) | Co-Founder · Since at least Oct 10, 2018 |
| Earl Douglas Other companies: Biomimetic Therapeutics Inc (General Counsel · May 10, 2006 – Mar 26, 2012 · Past) | General Counsel · Since at least Aug 14, 2023 |
| Liz Barrett Other companies: UroGen Pharma Ltd. (President and Chief Executive Officer · Since at least Nov 4, 2026) | President and Chief Executive Officer of UroGen, Former CEO of Novartis Oncology · Since at least Nov 6, 2026 |
| Allogene Media/Investor Contact:Christine CassianoEVP | Chief Corporate Affairs & Brand Strategy · Since at least Apr 16, 2026 |
| Annie Yoshiyama | Senior Vice President, Finance and Corporate Controller, and Principal Accounting Officer · Since at least Apr 23, 2026 |
| Benjamin M. Beneski | Senior Vice President, Chief Technical Officer · Since at least Jan 29, 2025 |
| Christine Cassiano | Executive Vice President, Chief Corporate Affairs and Brand Strategy Officer · Since at least Nov 3, 2026 |
| Franz B. Humer | Director · Since at least Jun 18, 2025 |
| Joshua Kazam | Co-Founder and Director · Since at least Jun 23, 2026 |
| Leslie Bryant | Executive Director, Corporate Communications · Since at least Nov 3, 2026 |
| Lillian Smith | VP, Corporate Counsel · Apr 1, 2023 – Apr 1, 2023 · Past |
| Owen Witte | Professor of Microbiology, Immunology and Molecular Genetics · Since at least Nov 6, 2026 |
| Rocio Manghani | Vice President, Market Access, Evidence & Strategy · Since at least Nov 5, 2026 |
| Susie Lundeen | Chief People Officer · Since at least Nov 6, 2026 |
| Veer Bhavnagri | General Counsel · Apr 16, 2020 – Mar 14, 2023 · Past |
| Yinlin Jack Chen | SVP, Finance · Aug 10, 2023 – Aug 10, 2023 · Past |
| Zachary Roberts | President and Chief Executive Officer · Since at least Nov 3, 2026 |